Order results by:
| Issue | Title | |
| Vol 19, No 3 (2025) | Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer | Abstract similar documents |
| A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, A. G. Solopova, D. M. Mamchich, E. D. Mun, D. V. Blinov, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya | ||
| "... in patients with/without long-term anticoagulant therapy (АСТ) as a part of secondary prevention of thrombotic ..." | ||
| Vol 19, No 2 (2025) | Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis | Abstract similar documents |
| A. V. Vorobеv, A. G. Solopova, N. V. Lomakin, V. O. Bitsadze, M. V. Kim, K. N. Grigoreva, K. V. Gadatskaia, V. N. Galkin, D. O. Utkin, I. Elalamy, A. D. Makatsariya | ||
| "... (VTE) and bleeding during long-term anticoagulant therapy (АСТ) in patients with stage III–IV ovarian ..." | ||
| Vol 10, No 1 (2016) | DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
| I. Tzoran, B. Brenner | ||
| "... Several direct oral anticoagulants (DOACs), namely, apixaban, rivaroxaban, and dabigatran ..." | ||
| Vol 16, No 2 (2022) | Anticoagulants: dose control methods and inhibitors | Abstract PDF (Eng) similar documents |
| V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris, A. D. Makatsariya | ||
| "... These days, anticoagulants are in great demand. They are used as a prophylaxis for thromboembolic ..." | ||
| Vol 15, No 3 (2021) | Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins | Abstract similar documents |
| V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, N. V. Pyatigorskaya, S. V. Akinshina, N. A. Makatsariya, K. E. Gotsiridze, N. N. Babaeva, K. N. Grigoreva, A. S. Shkoda, I. Elalamy, J.-C. Gris, S. Shulman | ||
| "... generation drugs with modified properties that reduce a bleeding risk while applied for a non-anticoagulant ..." | ||
| Vol 15, No 2 (2021) | Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation | Abstract similar documents |
| O. L. Mysik, M. S. Zainulina | ||
| "... , to substantiate the use of antiplatelet agents and anticoagulants in pregnant women with activated intravascular ..." | ||
| Vol 16, No 6 (2022) | Antithrombotic therapy in COVID-19 patients | Abstract similar documents |
| E. V. Slukhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. S. Shkoda, D. V. Blinov, V. I. Tsibizova, Z. Jinbo, S. Sheena, S. Sсhulman, J.-K. Gris, I. Elalamy, A. D. Makatsariya | ||
| "... of experts to develop recommendations for use of anticoagulants and antiplatelet agents in COVID-19 patients ..." | ||
| Vol 10, No 1 (2016) | ANTITHROMBOTIC THERAPY IN CANCER PATIENTS | Abstract similar documents |
| A. V. Vorobev, A. M. Chabrov, A. A. Savchenko, A. D. Makatsariya | ||
| "... The article describes the main anticoagulant drugs used in cancer patients, taking ..." | ||
| Vol 10, No 1 (2016) | HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, V. O. Bitsadze | ||
| "... anticoagulant therapy during all pregnancy. Acquired or genetic forms of thrombophilia also can increase ..." | ||
| Vol 19, No 1 (2025) | Genetic thrombophilia and antiphospholipid antibodies in women with early and late preeclampsia: a retrospective cohort study | Abstract similar documents |
| A. S. Antonova, J. Kh. Khizroeva, V. O. Bitsadze, M. V. Tretyakova, N. A. Makatsariya, E. R. Efendieva, A. Yu. Shatilina, E. M. Lyadnova | ||
| "... were examined for lupus anticoagulant (LA) and antiphospholipid antibodies (aPL). The screening test ..." | ||
| Vol 19, No 1 (2025) | Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome | Abstract similar documents |
| N. F. Kuneshko, V. V. Kim, E. M. Lyadnova, A. R. Metkina, M. N. Velieva, A. V. Lazarchuk, V. O. Bitsadze, M. V. Tretyakova, D. V. Blinov | ||
| "... of lupus anticoagulant (LA), anti-cardiolipin antibodies (aCL), anti-β2-glycoprotein 1 antibodies (anti-β2 ..." | ||
| Vol 19, No 1 (2025) | Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course | Abstract similar documents |
| A. D. Makatsariya, S. V. Akinshina, A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, N. A. Makatsariya, I. S. Kalashnikova, N. R. Gashimova, K. N. Grigoreva, I. A. Stepanov, I. M. Dikareva, A. Yu. Tatarintseva, A. V. Lazarchuk, A. R. Khisamieva, D. V. Blinov, P. Van Dreden, J.-Ch. Gris, I. Elalamy, G. Gerotziafas | ||
| "... management involves discontinuation of heparin and the initiation of using alternative anticoagulants ..." | ||
| Vol 18, No 1 (2024) | History of antiphospholipid syndrome | Abstract similar documents |
| М. Р. Drozhzhina, А. V. Vorobev | ||
| "... (APS) particularly describing how lupus anticoagulant was discovered and how scientists around ..." | ||
| Vol 16, No 2 (2022) | Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia | Abstract similar documents |
| E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova | ||
| "... acetylsalicylic acid (ASA) in preventing recurrence of early and late fetal growth retardation (FGR) in patients ..." | ||
| Vol 8, No 3 (2014) | ON THE ISSUE OF PROTEIN C SYSTEM DISORDERS IN PREGNANT WOMEN WITH VARIOUS OBSTETRIC PATHOLOGY IN PAST HISTORY | Abstract similar documents |
| I. A. Mikhaylidi | ||
| "... , and treatment C deficiency with increased risk of thrombosis. Activated protein C (aPC) exerts its anticoagulant ..." | ||
| Vol 11, No 2 (2017) | CLINICAL BASIS OF DIPYRIDAMOL USE IN OBSTETRIC PRACTICE | Abstract similar documents |
| S. V. Akinshina, V. O. Bitsadze, A. D. Makatsariya | ||
| "... of these pregnancy-associated abnormalities. An increasing number of direct and indirect anticoagulants have been ..." | ||
| Vol 17, No 4 (2023) | Markers of systemic endotheliosis in early-onset preeclampsia relapse | Abstract similar documents |
| M. G. Nikolaeva, V. Yu. Terekhina, A. V. Kudinov, I. I. Shakhmatov, A. P. Momot | ||
| "... и основную группу (n = 38) при рецидиве рПЭ (30 пациенток были исключены из исследования). У женщин ..." | ||
| Vol 16, No 5 (2022) | Clinical significance of hemostasiological screening for thrombophilia in pregnant women with former thrombosis | Abstract similar documents |
| J. Kh. Khizroeva, N. N. Babaeva, N. A. Makatsariya, I. Elalamy, J-C. Gris | ||
| "... program for women with former venous thrombosis and ischemic stroke to prevent recurrence of arterial ..." | ||
| Vol 5, No 1 (2011) | PARTICULAR FEATURES OF OVARIAN CYSTS AND ENDOMETRIOSIS TREATMENT | Abstract similar documents |
| I. S. Sidorova, A. L. Unanyan | ||
| "... , and in whom after surgical treatment, there was no recurrence during 2-3 years after surgery. For evaluation ..." | ||
| Vol 15, No 4 (2021) | Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics" | Abstract similar documents |
| article Editorial | ||
| "... heparins (LMWHs) have largely replaced unfractionated heparin as the anticoagulant. However, in case ..." | ||
| Vol 15, No 6 (2021) | COVID-19 and thrombotic microangiopathy | Abstract PDF (Eng) similar documents |
| E. V. Sluhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. S. Shkoda, O. P. Artyukov, V. I. Tsibizova, A. L. Mishchenko, K. N. Grigorieva, J.-С. Gris, E. Elalamy, A. D. Makatsariya | ||
| "... reduce mortality due to the novel disease. Heparins and direct oral anticoagulants are the mainstay ..." | ||
| Vol 17, No 6 (2023) | Maternal blood proteomics during relapse of early preeclampsia | Abstract similar documents |
| M. G. Nikolaeva, V. Yu. Terekhina, A. P. Momot | ||
| "... Цель: изучить вклад эндотелиальных белков материнской крови в реализацию рецидива ранней ..." | ||
| Vol 15, No 4 (2021) | Management of antithrombin III deficiency in pregnancy: a representative case and a literature review | Abstract PDF (Eng) similar documents |
| S. V. Akinshina, P. K. Genina, V. O. Bitsadze, J. Kh. Khizroeva, V. I. Tsibizova, A. D. Makatsariya | ||
| "... thrombotic and obstetric complications even despite using therapeutic doses of anticoagulants. Indications ..." | ||
| Vol 9, No 3 (2015) | CLINICAL LABORATORY INDICATORS OF PREGNANT WITH ANTIPHOSPHOLIPID SYNDROME IN COMPLEX THERAPY WITH USING INTRAVENOUS IMMUNOGLOBULIN | Abstract similar documents |
| V. I. Linnikov | ||
| "... groups depending on therapy. The patients in group I (n=35) - received anticoagulant, antiplatelet ..." | ||
| Vol 8, No 2 (2014) | THROMBOSIS OF UNUSUAL SITES AND THROMBOPHILIA | Abstract similar documents |
| S. V. Akinshina, A. D. Makatsariya | ||
| "... should be performed and timely administration of anticoagulant therapy is critical. Analysis of genetic ..." | ||
| Vol 15, No 5 (2021) | Prophylaxis and management of venous thromboembolism during pregnancy and postpartum period | Abstract similar documents |
| V. Ya. Khryshchanovich, N. Ya. Skobeleva | ||
| "... and postpartum, by taking into account a balance between risks and benefits of using anticoagulants. Materials ..." | ||
| Vol 18, No 6 (2024) | Chemotherapy and hemostasis disorders | Abstract similar documents |
| E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya | ||
| "... of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation ..." | ||
| Vol 8, No 1 (2014) | ASSISTED REPRODUCTIVE TECHNOLOGY AND ANTIPHOSPHOLIPID SYNDROME | Abstract similar documents |
| J. Kh. Khizroeva, T. M. Mashkova | ||
| "... damage to all of its protective components including the endothelial barrier, natural anticoagulant ..." | ||
| Vol 15, No 3 (2021) | Thrombophilia identified as a risk factor for thrombogenesis in cancer patients | Abstract similar documents |
| A. V. Vorobev, A. D. Makatsariya, V. O. Bitsadze, A. G. Solopova, D. A. Ponomarev | ||
| "... to a high risk of thrombogenesis and require to preventive application of anticoagulant therapy. ..." | ||
| Vol 15, No 2 (2021) | Risks of cerebrovascular disorders associated with combined hormonal contraceptives | Abstract similar documents |
| M. G. Novosartyan | ||
| Vol 12, No 3 (2018) | Pregnancy management and successful delivery in a patient with Bland-White-Garland syndrome and a prosthetic mitral valve | Abstract similar documents |
| M. O. Arslanbekova, D. Kh. Khizroeva, N. V. Samburova, E. S. Egorova | ||
| Vol 14, No 1 (2020) | Disseminated intravascular coagulation in perinatal medicine | Abstract similar documents |
| M. A. Mingalimov, K. N. Grigorieva, M. V. Tretyakova, I. Elalamy, Kh. G. Sultangadzhieva, V. O. Bitsadze, J. Kh. Khizroeva, A. D. Makatsariya | ||
| Vol 14, No 1 (2020) | Management of pregnancy and labor in female with combination of homozygous Leiden and heterozygous prothrombin G20210A mutations | Abstract similar documents |
| M. O. Arslanbekova, J. Kh. Khizroeva | ||
| "... ) associated with high risk of thrombosis by using proper anticoagulant therapy. It was underlined that females ..." | ||
| Vol 15, No 5 (2021) | Pathogenetically justified tactics of management of pregnancy with retrochorial hematoma | Abstract similar documents |
| K. G. Sultangadzhieva, N. N. Babaeva, E. S. Egorova, J. Kh. Khizroeva, M. G. Sultangadzhiev | ||
| "... in the genes of factor (F) V Leiden and prothrombin (FII) G20210A; blood levels of lupus anticoagulant (LA ..." | ||
| Vol 12, No 3 (2018) | To the issue of borderline ovarian tumors | Abstract similar documents |
| A. G. Solopova, A. Yu. Vlasina, N. A. Makatsariya, V. S. Moskvichyova, L. N. Sandzhieva | ||
| "... , диагностике, лечению, выявлению рецидивов и сохранению репродуктивного потенциала. ..." | ||
| Vol 14, No 4 (2020) | Errors of antithrombotic therapy in management of pregnancy and childbirth after in vitro fertilization and transfer of two embryos | Abstract similar documents |
| N. S. Stuleva, D. A. Doronicheva, I. V. Khamani, E. A. Orudzhova | ||
| Vol 14, No 2 (2020) | Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome | Abstract PDF (Eng) similar documents |
| A. D. Makatsariya, K. N. Grigoreva, M. A. Mingalimov, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, I. Elalamy, A. S. Shkoda, V. B. Nemirovskiy, D. V. Blinov, D. V. Mitryuk | ||
| Vol 12, No 1 (2018) | MANAGEMENT OF PREGNANCY AND DELIVERY IN A WOMAN WITH HOMOZYGOUS MUTATION OF PROTHROMBIN (Thr165Met) AND RECURRENT PULMONARY EMBOLISM ON THE BACKGROUND OF HORMONAL CONTRACEPTION | Abstract similar documents |
| N. M. Khamani | ||
| Vol 18, No 3 (2024) | Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis | Abstract similar documents |
| A. D. Makatsariya, A. V. Vorobev, A. V. Lazarchuk, S. E. Einullaeva, N. A. Gomenko, F. A. Magomedova, V. O. Bitsadze, J. Kh. Khizroeva, N. A. Makatsariya, V. B. Zubenko, M. V. Tretyakova, D. V. Blinov, F. E. Yagubova, N. R. Gashimova, K. N. Grigoreva, M. A. Ponimanskaya, O. N. Li, A. V. Mostovoi, A. L. Karpova, J-C. Gris, I. Elalamy | ||
| Vol 18, No 5 (2024) | Corrigendum to «Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis» (https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.530) | Abstract similar documents |
| A. D. Makatsariya, A. V. Vorobev, A. V. Lazarchuk, S. E. Einullaeva, N. A. Gomenko, F. A. Magomedova, V. O. Bitsadze, J. Kh. Khizroeva, N. A. Makatsariya, V. B. Zubenko, M. V. Tretyakova, D. V. Blinov, F. E. Yagubova, N. R. Gashimova, K. N. Grigoreva, M. A. Ponimanskaya, O. N. Li, A. V. Mostovoi, A. L. Karpova, J.-C. Gris, I. Elalamy | ||
| Vol 10, No 3 (2016) | ROLE OF INOSINE PRANOBEX IN MANAGEMENT OF HPV-ASSOCIATED DISEASES: PROBLEMS AND PROSPECTIVE | Abstract similar documents |
| V. O. Bitsadze, N. M. Khamani, N. A. Makatsariya | ||
| "... at present time. Isoprinosine saves a woman from the HPV, reducing the possibility of recurrence ..." | ||
| Vol 14, No 1 (2020) | Pathogenetically differentiated management of pregnancy in patients with retrochorial hematoma | Abstract similar documents |
| Kh. G. Sultangadzhieva, J. Kh. Khizroeva | ||
| "... anticoagulant, antiphospholipid antibodies (AFA), antibodies to cardiolipin, fi2-glycoprotein I, to annexin V ..." | ||
| Vol 15, No 3 (2021) | Endometriosis-associated cancer: modern aspects of etiopathogenesis, treatment and rehabilitation | Abstract similar documents |
| E. Begovich, A. G. Solopova, V. O. Bitsadze, S. V. Khlopkova, E. A. Orudzhova | ||
| "... for early diagnosing recurrences that will provide early diagnostics ovarian ЕАС and improve the main ..." | ||
| Vol 15, No 3 (2021) | Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract | Abstract similar documents |
| G. B. Dikke, A. A. Sukhanov, I. I. Kukarskaya, V. V. Ostromenskii | ||
| "... Aim: to increase the effectiveness of combination therapy and reduce frequency of recurrences ..." | ||
| Vol 13, No 3 (2019) | Vaginal biocenosis in pregnant women with recurrent bacterial vaginosis after treatment with recombinant human interferon alpha-2b | Abstract similar documents |
| A. V. Podgornaya, A. Sh. Makhmutkhodzhaev | ||
| "... examined for the rate of BV recurrence and also tested for their vaginal bacteria and levels of β-defensin ..." | ||
| Vol 15, No 6 (2021) | Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation | Abstract similar documents |
| E. A. Orudzhova | ||
| "... cardiolipin, β2 -glycoprotein 1, annexin V, prothrombin, etc. (IgG/IgM isotypes); lupus anticoagulant ..." | ||
| Vol 14, No 6 (2020) | Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies | Abstract similar documents |
| Yu. S. Dolgova, D. R. Eremeeva, M. S. Zainulina | ||
| "... and IgG classes were measured by using ELISA, lupus anticoagulant (LA) was estimated by using ..." | ||
| Vol 10, No 3 (2016) | ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY | Abstract similar documents |
| A. V. Khromylev, A. D. Makatsariya | ||
| "... anticoagulants. Due to the therapy with the use of LMWH the development of thromboembolic episodes was prevented ..." | ||
| Vol 11, No 3 (2017) | RARE THROMBOSIS LOCALIZATION IN A CANCER PATIENT WITH COMBINED THROMBOPHILIA: A CLINICAL CASE | Abstract similar documents |
| A. V. Vorobiev, A. D. Makatsaria | ||
| "... anticoagulant therapy was recommended. ..." | ||
| 1 - 50 of 87 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
